ATE179605T1 - Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation - Google Patents
Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalationInfo
- Publication number
- ATE179605T1 ATE179605T1 AT92101977T AT92101977T ATE179605T1 AT E179605 T1 ATE179605 T1 AT E179605T1 AT 92101977 T AT92101977 T AT 92101977T AT 92101977 T AT92101977 T AT 92101977T AT E179605 T1 ATE179605 T1 AT E179605T1
- Authority
- AT
- Austria
- Prior art keywords
- inhalation
- antireactive
- salicylic acid
- drugs
- acetyl salicylic
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 229960001138 acetylsalicylic acid Drugs 0.000 title 1
- 230000001088 anti-asthma Effects 0.000 title 1
- 239000002152 aqueous-organic solution Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 abstract 1
- 229960000991 ketoprofen Drugs 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- WZWYJBNHTWCXIM-UHFFFAOYSA-N tenoxicam Chemical compound O=C1C=2SC=CC=2S(=O)(=O)N(C)C1=C(O)NC1=CC=CC=N1 WZWYJBNHTWCXIM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002871 tenoxicam Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91101818 | 1991-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE179605T1 true ATE179605T1 (de) | 1999-05-15 |
Family
ID=8206393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92101977T ATE179605T1 (de) | 1991-02-09 | 1992-02-06 | Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6051566A (de) |
| JP (1) | JPH0648958A (de) |
| KR (1) | KR920016086A (de) |
| AT (1) | ATE179605T1 (de) |
| AU (1) | AU662509B2 (de) |
| BR (1) | BR9200429A (de) |
| CA (1) | CA2060937A1 (de) |
| CZ (1) | CZ281970B6 (de) |
| DE (1) | DE69229070T2 (de) |
| HU (1) | HUT60917A (de) |
| IE (1) | IE920427A1 (de) |
| IL (1) | IL100896A (de) |
| MX (1) | MX9200571A (de) |
| NO (1) | NO179893C (de) |
| NZ (1) | NZ241542A (de) |
| ZA (1) | ZA92890B (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| MXPA02001323A (es) | 2000-05-10 | 2004-07-16 | Alliance Pharma | Microgranulos con base fosfolipida para la liberacion de farmaco. |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US7256184B2 (en) * | 2000-10-16 | 2007-08-14 | Rodriguez Victorio C | Treatment of aging disorders in humans |
| CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US7766013B2 (en) * | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| AU2002310085B2 (en) * | 2001-05-24 | 2008-09-04 | Alexza Pharmaceuticals, Inc. | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
| US6759029B2 (en) * | 2001-05-24 | 2004-07-06 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan and zolmitriptan through an inhalation route |
| US6805853B2 (en) * | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| WO2002094246A2 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| AU2002352726A1 (en) | 2001-11-15 | 2003-06-10 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
| WO2003057188A1 (en) | 2001-11-21 | 2003-07-17 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| SI1458360T1 (sl) * | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
| EP1503744A1 (de) | 2002-05-13 | 2005-02-09 | Alexza Molecular Delivery Corporation | Verabreichung von aminenhaltigen arzneistoffen durch inhalation |
| US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
| US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| EP1567164B1 (de) * | 2002-11-26 | 2009-01-14 | Alexza Pharmaceuticals, Inc. | Verwendung von loxapine für die herstellung eines mittels zur behandlung von schmerz |
| JP2006514633A (ja) * | 2002-11-26 | 2006-05-11 | アレックザ ファーマシューティカルズ， インコーポレイテッド | 吸入によって送達される抗精神病薬を用いた頭痛の治療 |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| JP4601619B2 (ja) | 2003-05-21 | 2010-12-22 | アレックザ ファーマシューティカルズ， インコーポレイテッド | 内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| WO2006022714A1 (en) | 2004-08-12 | 2006-03-02 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| US8455437B2 (en) * | 2005-02-04 | 2013-06-04 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Method to predict and prevent oxygen-induced inflammatory tissue injury |
| ITMI20050417A1 (it) * | 2005-03-15 | 2006-09-16 | Medestea Res & Production S R L | Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica |
| US20070203104A1 (en) * | 2006-02-09 | 2007-08-30 | Chaudhry Saeed M | Pharmaceutical Formulations |
| JP5094197B2 (ja) * | 2006-04-27 | 2012-12-12 | 第一三共ヘルスケア株式会社 | 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物 |
| US20080216828A1 (en) | 2007-03-09 | 2008-09-11 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| DE102008004386A1 (de) * | 2008-01-14 | 2009-07-23 | Activaero Gmbh | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
| EP2280995A2 (de) * | 2008-04-29 | 2011-02-09 | Wyeth LLC | Verfahren zur behandlung von entzündungen |
| KR101704815B1 (ko) * | 2009-08-21 | 2017-02-09 | 포항공과대학교 산학협력단 | Ｉｌ－１７ 매개 염증질환의 치료를 위한 조합 제제 및 이를 이용한 치료 방법 |
| US20130281405A1 (en) * | 2012-04-02 | 2013-10-24 | Lenard M. Lichtenberger | Use of pc-nsaids to treat and/or prevent pulmonary inflammation |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| EP3607941A1 (de) | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Trockenpulverformulierungen und verfahren zur verwendung |
| TWI586383B (zh) * | 2014-04-18 | 2017-06-11 | 林信湧 | 一種用於治療關節炎之吸入式醫藥組成物及其備製方法 |
| US10328045B2 (en) | 2014-09-12 | 2019-06-25 | Children's Medical Center Corporation, Inc. | Dietary emulsion formulations and methods for using the same |
| US11723864B2 (en) * | 2015-05-29 | 2023-08-15 | The Texas A&M University System | Antimicrobial and anti-inflammatory compositions |
| EP3746138A4 (de) | 2018-02-02 | 2021-11-03 | Alexza Pharmaceuticals, Inc. | Elektrische kondensationsaerosolvorrichtung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244899A (en) * | 1985-02-04 | 1993-09-14 | G. D. Searle And Co. | Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders |
| US4885287A (en) * | 1988-08-09 | 1989-12-05 | University Of Kentucky Research Foundation | Novel method of administering aspirin and dosage forms containing same |
-
1992
- 1992-02-06 DE DE69229070T patent/DE69229070T2/de not_active Expired - Lifetime
- 1992-02-06 AT AT92101977T patent/ATE179605T1/de not_active IP Right Cessation
- 1992-02-07 ZA ZA92890A patent/ZA92890B/xx unknown
- 1992-02-07 NZ NZ241542A patent/NZ241542A/en unknown
- 1992-02-07 IL IL100896A patent/IL100896A/en not_active IP Right Cessation
- 1992-02-07 IE IE042792A patent/IE920427A1/en unknown
- 1992-02-07 AU AU10772/92A patent/AU662509B2/en not_active Ceased
- 1992-02-07 HU HU9200389A patent/HUT60917A/hu unknown
- 1992-02-07 NO NO920504A patent/NO179893C/no unknown
- 1992-02-07 BR BR929200429A patent/BR9200429A/pt not_active Application Discontinuation
- 1992-02-07 KR KR1019920001737A patent/KR920016086A/ko not_active Application Discontinuation
- 1992-02-07 CZ CS92352A patent/CZ281970B6/cs unknown
- 1992-02-07 JP JP4056158A patent/JPH0648958A/ja active Pending
- 1992-02-10 CA CA002060937A patent/CA2060937A1/en not_active Abandoned
- 1992-02-10 MX MX9200571A patent/MX9200571A/es unknown
-
1998
- 1998-03-02 US US09/032,973 patent/US6051566A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2060937A1 (en) | 1992-08-10 |
| US6051566A (en) | 2000-04-18 |
| HUT60917A (en) | 1992-11-30 |
| IL100896A (en) | 1998-02-22 |
| AU1077292A (en) | 1992-08-13 |
| NO920504D0 (no) | 1992-02-07 |
| JPH0648958A (ja) | 1994-02-22 |
| HU9200389D0 (en) | 1992-04-28 |
| DE69229070T2 (de) | 1999-11-18 |
| IL100896A0 (en) | 1992-11-15 |
| BR9200429A (pt) | 1992-10-13 |
| CZ281970B6 (cs) | 1997-04-16 |
| NZ241542A (en) | 1996-05-28 |
| NO920504L (no) | 1992-08-10 |
| DE69229070D1 (de) | 1999-06-10 |
| CS35292A3 (en) | 1992-08-12 |
| NO179893B (no) | 1996-09-30 |
| AU662509B2 (en) | 1995-09-07 |
| IE920427A1 (en) | 1992-08-12 |
| ZA92890B (en) | 1992-12-30 |
| MX9200571A (es) | 1992-12-01 |
| NO179893C (no) | 1997-01-08 |
| KR920016086A (ko) | 1992-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE179605T1 (de) | Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation | |
| TR199500856A2 (tr) | Nefesle ice cekilerek alinan farmasötik bilesim. | |
| NO305537B1 (no) | Farmas°ytisk preparat inneholdene et definert lipidsystem, og anvendelse av lipidsystemet | |
| ATE61050T1 (de) | Pyridazinamine wirksam gegen viren. | |
| RU94022269A (ru) | Состав аэрозоля, находящийся под давлением | |
| DK0706383T3 (da) | Praeparat til inhalation | |
| TR200002692T2 (tr) | Aerosol haline getirilen aktif maddenin verilmesi. | |
| CA2159915A1 (en) | Systemic effects of nitric oxide inhalation | |
| BR9908587A (pt) | Inalador de pó | |
| SE8305485D0 (sv) | Galenic compositions comprising calcitonin and their use | |
| MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
| AU1077092A (en) | Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflamatory drugs | |
| EP0919229A3 (de) | Antireaktiver und antiasthmatischer Aktivität von inhalierte nichtsteroidale Entzündungshemmer | |
| NO972377D0 (no) | Indolderivater og medisinsk anvendelse derav | |
| ES2093829T3 (es) | Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias. | |
| HUP9601526A2 (hu) | Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
| IE34806L (en) | Pharmaceutical composition | |
| GB1154454A (en) | New Anthranilic Acid Derivatives | |
| GB1294681A (en) | Novel bis-thiachromonyl compounds their preparation and use | |
| Prober | Ribavirin: A new weapon against respiratory viruses?. | |
| JPS5634624A (en) | Central nervous system depressant | |
| DE69325531D1 (de) | Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen | |
| IT8348395A0 (it) | Composizioni farmaceutiche a basedi solfonammidi e loro impiego per combattere l'obesita' | |
| JPS57114518A (en) | Hypotensive agent | |
| ITFI920029V0 (it) | " inalatore per addurre aria da inspirare, per impiego in presenza diatmosfere nocive " |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |